Drug
Vilanterol trifenatate clinical trials
Also written GW642444M.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2007 (5)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 5 |
| 2008 | 1 |
| 2010 | 1 |
| 2019 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 1
Often tested with
Tested in the same studies.
Fluticasone furoate (4) · Vilanterol α-phenyl cinnamate (3) · Umeclidinium bromide (1) · Ketoconazole (1)
Studies
Open first, then newest update. How each study uses vilanterol trifenatate is read from its arms, and is right about nine times in ten.
Testing it · 10
- Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled AsthmaActive, not recruitingPhase 4GlaxoSmithKlineNCT06372496Written as Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
- Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone FuroateCompletedPhase 2Bispebjerg HospitalNCT03739294Written as Fluticasone Furoate/ Vilanterol Trifenatate
- A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic PatientsCompletedPhase 1GlaxoSmithKlineNCT00463697Written as GW642444M (25, 100 & 400 mcg)
- Safety, Blood Levels and Effects of GW642444CompletedPhase 1GlaxoSmithKlineNCT00469040Written as GW642444M for 14 days
- Comparing Two Respiratory Drugs When Used In Combination And Separately From A Novel Inhaler Device In Healthy SubjectsCompletedPhase 1GlaxoSmithKlineNCT00538057Written as GW685698X & GW642444M
- Drug Interaction Study to Investigate Co-administration of GW642444M With KetoconazoleCompletedPhase 1GlaxoSmithKlineNCT00866515Written as Ketoconazole + GW642444M
- A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In COPD Patients.CompletedPhase 2GlaxoSmithKlineNCT00519376Written as GW642444M
- Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic ResponseCompletedPhase 2GlaxoSmithKlineNCT01128595Written as GW642444M
- Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.CompletedPhase 2GlaxoSmithKlineNCT00600171Written as GW642444M
- Study to Assess GW642444 in Asthma PatientsCompletedPhase 2GlaxoSmithKlineNCT00381667Written as GW642444M
As the comparator · 1 — what is tested is compared with vilanterol trifenatate
Codes
What other systems call vilanterol trifenatate · ClinicalTrials.gg INT014762
- UNII (FDA) 40AHO2C6DGVILANTEROL TRIFENATATEConfirmed FDA, Wikidata
- RxNorm 1424883Confirmed FDA, Wikidata
- Wikidata Q27145087vilanterol trifenatateConfirmed FDA, Wikidata
- NCI Thesaurus C152876Vilanterol TrifenatateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 40AHO2C6DG | VILANTEROL TRIFENATATE | Confirmed FDA, Wikidata |
| RxNorm | 1424883 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27145087 | vilanterol trifenatate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152876 | Vilanterol Trifenatate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.